Skip to Content
Author: The BCW

Leave a Comment

Regeneron Antibody Cocktail Proved Effective Against COVID-19

More good news from BCW member Regeneron Pharmaceuticals which this week released a new analysis of data showing that its monoclonal antibody cocktail known as REGEN-COV is effective against Covid-19 infection.

Positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases showed that the drug reduces by 81.6% the risk of being infected by the Covid-19 virus, SARS-CoV-2. The data are from an ongoing clinical trial in which a group of participants received a 1,200-milligram dose of the drug in four injections administered under the skin.

The clinical trial involved 1,683 people who were tested to be sure they were not infected with Covid and did not have antibodies for the virus. Participants in the trial received either the Regeneron drug or a placebo. It was a double-blind study that initially kept secret the identities of participants who received the monoclonal antibodies and those who did not.

“Today’s new data demonstrate how a single dose of REGEN-COV can help protect people from Covid-19 for many months after administration,” said Myron S. Cohen, a doctor who leads the monoclonal antibody efforts for the Covid Prevention Network, which is sponsored by the National Institutes of Health.

George D. Yancopoulos, President and Chief Scientific Officer at Regeneron, said, “These data add to the increasing body of evidence supporting use of REGEN-COV to prevent Covid-19 in uninfected individuals, which may be especially useful for the many immunocompromised people who do not respond adequately to vaccines. With infections still occurring despite widespread vaccination, the immunocompromised face an ongoing risk of encountering the virus during their daily lives.”

Yancopoulos and Regeneron CEO Leonard Schleifer were awarded the BCW’s 2021 Global Leadership Laureate at last month’s Annual Dinner for their innovation, their development of the REGEN-COV therapy for post-exposure prevention of Covid-19, and for the company’s multi-billion-dollar investments in Westchester County.

Similar News Items

The BCW’s state advocacy program was actively engaged throughout the session including reaching out to legislators during the final last hours of the session. Countless memorandums of support and opposition on bills of importance to the business community were issued to the Legislature; and countless Zoom meetings were held. Additionally, the BCW was in constant contact with […]

Read Article

City, County and State officials held a press conference this week at Pugsley Park in Peekskill to discuss the city’s recent certification as a New York State Pro-Housing Community, its $10 million award from the Mid-Hudson Momentum Fund, and to celebrate the opening of Pugsley Park with a ribbon cutting. Over 50 people were in […]

Read Article

The BCW’s Government Action Council hosted its sixth annual Board of Legislators Reception on Tuesday, where BCW members shared their concerns with members of the Westchester County Board of Legislators. BOL Chair Vedat Gashi and BOL Vice Chair Jose Alvarado updated BCW members on the BOL’s ongoing activities, including preparing for next year’s County Executive […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

JOIN NOW!
The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top